(Q36841565)

16 August 2017

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial (English)

1 reference

16 August 2017

1 reference

13

Hans-Olov Adami

1 reference

16 August 2017

Juni Palmgren

12

0 references

Hans Garmo

object named as

Hans Garmo

series ordinal

5

0 references

Lars Holmberg

series ordinal

2

object named as

Lars Holmberg

1 reference

16 August 2017

1

Anna Bill-Axelson

1 reference

16 August 2017

6

Christer Busch

1 reference

16 August 2017

7

Stig Nordling

1 reference

16 August 2017

8

Michael Häggman

1 reference

16 August 2017

9

Swen-Olof Andersson

1 reference

16 August 2017

11

Anders Spångberg

1 reference

16 August 2017

14

Jan-Erik Johansson

1 reference

16 August 2017

4

Mirja Ruutu

1 reference

16 August 2017

10

Stefan Bratell

1 reference

16 August 2017

Frej Filén

3

1 reference

PMCID

2518167

16 August 2017

Scandinavian Prostate Cancer Group Study Number 4

series ordinal

15

1 reference

PMCID

2518167

16 August 2017

language of work or name

English

0 references

publication date

11 August 2008

1 reference

Journal of the National Cancer Institute

16 August 2017

1 reference

16 August 2017

100

1 reference

16 August 2017

1144-1154

1 reference

16 August 2017

16

1 reference

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Impact of positive surgical margins after radical prostatectomy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Prognostic markers under watchful waiting and radical prostatectomy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Radical prostatectomy versus watchful waiting in early prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Ethics of a prostate cancer screening trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

A New Design for Randomized Clinical Trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Quality of life after radical prostatectomy or watchful waiting.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518167

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

5 September 2018

2 references

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN255

21 January 2018

12 December 2020

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 reference

12 December 2020

Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit

1 reference

12 December 2020

The role of radical prostatectomy in the management of prostatic cancer

1 reference

12 December 2020

Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJN255

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

PMCID

2518167